How to buy Moderna (MRNA) stocks

Moderna is a biotechnology business based in the US. Moderna shares (MRNA) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $24.72 , which is a decrease of 5.67% over the previous week. Moderna employs 5,800 staff and has a trailing 12-month revenue of around $3.2 billion.

Our top picks for where to buy Moderna stock

Buy Moderna stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Moderna stock price (NASDAQ: MRNA)

Use our graph to track the performance of MRNA stocks over time.

Moderna stocks at a glance

• Key figures

Information last updated 2025-04-17.

Latest market close	$24.72
52-week range	$23.15 - $170.47
50-day moving average more info button	$31.44
200-day moving average more info button	$56.88
Wall St. target price	$51.14
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-9.28

Is it a good time to buy Moderna stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Moderna financials

Revenue TTM	$3.2 billion
Gross profit TTM	$-2,771,000,064
Return on assets TTM	-15.14%
Return on equity TTM	-28.77%
Profit margin	-110.04%
Book value	$28.24
Market Capitalization more info button	$9.7 billion

TTM: trailing 12 months

Moderna stock dividends

We're not expecting Moderna to pay a dividend over the next 12 months.

Moderna stock price volatility

Over the last 12 months, Moderna's stocks have ranged in value from as little as $23.15 up to $170.47. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 2.233. This would suggest that Moderna's stocks are significantly more volatile than the average for this exchange and represent a higher risk.

Moderna overview

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Moderna is owned by insiders or institutions?
Currently 7.268% of Moderna stocks are held by insiders and 72.828% by institutions. How many people work for Moderna?
Latest data suggests 5,800 work at Moderna. When does the fiscal year end for Moderna?
Moderna's fiscal year ends in December. Where is Moderna based?
Moderna's address is: 325 Binney Street, Cambridge, MA, United States, 02142 What is Moderna's ISIN number?
Moderna's international securities identification number is: US60770K1079 What is Moderna's CUSIP number?
Moderna's Committee on Uniform Securities Identification Procedures number is: 60770K107

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.